Regarding CCL11, considerable evidence exists on the role of this chemokine in the progression of neurodegenerative diseases (e.g., schizophrenia or dementia patients) [22, 48], but contradictory results have been reported in relation to MDD. Here, CCL11 is linked to major depressive disorder.